Xenon Pharmaceuticals (XENE) has released an update.
Xenon Pharmaceuticals Inc., specializing in developing treatments for neurological and psychiatric disorders, has announced its participation in the upcoming BofA Securities Health Care Conference 2024. The event, which will feature a fireside chat with Xenon’s President and CEO Ian Mortimer and CFO Sherry Aulin, is set to take place on May 15 in Las Vegas. Interested parties can access a live webcast of the presentation on Xenon’s website, with a replay available post-event.
For further insights into XENE stock, check out TipRanks’ Stock Analysis page.
